CBD – Fractionation Research

Organisation: Cannasouth Plant Research
Grant Number: A17025
Grant Amount: $20,869
Grant Type: Agribusiness Innovation Grant

Cannasouth Plant Research (ex Gentec Plant Research Limited) is a biopharmaceutical, research company based at Waikato Innovation Park, Ruakura, Hamilton.  Cannasouth has been established to focus on the research of medically beneficial attributes of cannabinoid compounds such as CBD – THC and associated chemical structures that are produced by the plant.

Cannasouth working in collaboration with Waikato University and with funding support from AGMARDT has now produced New Zealand’s first MoH approved pharmaceutical grade purity cannabinoid CBD – CDBA – THC isolate extracts.  Using raw plant material sourced from its Waikato based Industrial Hemp breeding programmes, Cannasouth has laid a solid foundation in the ongoing development of the nascent medical cannabis research sector in New Zealand.  This Masters Study on CBD – Fractionation Research, was leveraged off the first ever New Zealand based cannabinoid Super Critical Co2 Fluid extraction trial that Cannasouth conducted with support from Callaghan Innovation.

Worldwide research on cannabinoid compounds is showing genuine efficacy regards positive outcomes for human and animal health across a number of disease models.  This is an exciting emerging area of medical research with cannabinoid delivery system technologies and the science that underpins them being a key area Cannasouth is now focusing research on. Issues such as Bioavailability, Nano-formulation and Lipo Encapsulation of CBD show that there is clear potential for improved formulations and delivery methods that will increase the bioavailability of CBD while decreasing the production of undesirable metabolites.

“Having AGMARDT as a research funding partner has made a substantial difference regards getting this research project off the ground”. Nic Foreman, Director of Research at Cannasouth.

We are grateful for the assistance the AGMARDT Grant provided. It has allowed Freshco to direct sales and manage our own destinies in each market enabling us to extract more value from the supply chain to the consumer.

John Mangan / Director, Freshco

AGMARDT supports and enables. Projects and people benefit from funding; New Zealand benefits from development of ideas, technologies, approaches and leadership. In particular, the trust facilitates information dissemination: AGMARDT is the catalyst for ripples that spread through the primary sector.

Dr Jacqueline Rowarth /

AGMARDT's support of Texus in the above process tangibly accelerated the development of the above essential activities and testing of market entry strategy, while also exposing Texus management to cutting-edge thought leadership around market shaping and the levers that can be applied to scope and facilitate such shaping.

Nick Davenport / CEO, Texus Fibre Industry Leader Scholarship Winner

The support from AGMARDT has enabled us to gain greater insights into farmer behaviour across all sectors and which will assist accelerated uptake of the livestock exchange and enhance market opportunities for all farmers.

Jason Roebuck / Managing Director, Stock-X Limited